Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 23:150:e170.
doi: 10.1017/S0950268822001492.

Burden of multidrug and extensively drug-resistant ESKAPEE pathogens in a secondary hospital care setting in Greece

Affiliations

Burden of multidrug and extensively drug-resistant ESKAPEE pathogens in a secondary hospital care setting in Greece

Evangelos I Kritsotakis et al. Epidemiol Infect. .

Abstract

Bacterial antibiotic resistance (AMR) is a significant threat to public health, with the sentinel 'ESKAPEE' pathogens, being of particular concern. A cohort study spanning 5.5 years (2016-2021) was conducted at a provincial general hospital in Crete, Greece, to describe the epidemiology of ESKAPEE-associated bacteraemia regarding levels of AMR and their impact on patient outcomes. In total, 239 bloodstream isolates were examined from 226 patients (0.7% of 32 996 admissions) with a median age of 75 years, 28% of whom had severe comorbidity and 46% with prior stay in ICU. Multidrug resistance (MDR) was lowest for Pseudomonas aeruginosa (30%) and Escherichia coli (33%), and highest among Acinetobacter baumannii (97%); the latter included 8 (22%) with extensive drug-resistance (XDR), half of which were resistant to all antibiotics tested. MDR bacteraemia was more likely to be healthcare-associated than community-onset (RR 1.67, 95% CI 1.04-2.65). Inpatient mortality was 22%, 35% and 63% for non-MDR, MDR and XDR episodes, respectively (P = 0.004). Competing risks survival analysis revealed increasing mortality linked to longer hospitalisation with increasing AMR levels, as well as differential pathogen-specific effects. A. baumannii bacteraemia was the most fatal (14-day death hazard ratio 3.39, 95% CI 1.74-6.63). Differences in microbiology, AMR profile and associated mortality compared to national and international data emphasise the importance of similar investigations of local epidemiology.

Keywords: ESKAPE; hospital epidemiology; microbial drug resistance; mortality; secondary care; survival analysis.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Resistance levels of ESKAPEE bloodstream isolates (n = 235). Four isolates were excluded as full antibiogram data were missing (one A. baumannii, two E. coli and one K. pneumoniae).
Fig. 2.
Fig. 2.
Cumulative incidence functions for in-hospital mortality (on the left) and discharge alive (on the right) by antimicrobial resistance level (upper panel) and ESKAPEE organism (lower panel) isolated from blood in 226 patients. Lower incidence of hospital discharge alive indicates longer hospitalisation after bacteraemia onset. MDR, multidrug resistant; XDR extensively drug resistant.

References

    1. Antimicrobial Resistance Collaborators (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629–655. - PMC - PubMed
    1. Karakonstantis S, Kritsotakis EI and Gikas A (2020) Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems. Infection 48, 835–851. - PMC - PubMed
    1. De Oliveira DMP et al. (2020) Antimicrobial resistance in ESKAPE Pathogens. Clinical Microbiology Reviews 33, e00181-19. - PMC - PubMed
    1. Tacconelli E et al. (2018) Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infectious Diseases 18, 318–327. - PubMed
    1. Kritsotakis EI et al. (2017) Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in Greece. Infection and Drug Resistance 10, 317–328. - PMC - PubMed

Substances